While Sydvaranger is progressing as scheduled, with a PEA planned for Q1’25 and a DFS by mid-2025, Dannemora has encountered a new hurdle with power supply, introducing additional uncertainty and delays for both the final investment decision and project financing, as well as the commencement of essential site preparations. On top of this, iron ore prices have seen a subdued quarter but the company’s positioning in high-grade iron ore production aligns with positive long-term market trends. While the case in GRANGEX may now require additional patience from investors, we maintain our view on the high revaluation potential in GRANGEX, with an rNPV-based fair value to SEK 70 per share, contingent on the resolution of these critical obstacles at Dannemora.
Johan Widmark | 2024-11-07 12:00
PEA in Q1 and DFS expected in mid-2025
GRANGEX’s efforts to restart production at Norway’s largest and Europe’s third-largest iron ore mine, Sydvaranger, have progressed over the quarter. Following the completion of an Optimization Study for the Sydvaranger mine restart in Q3, a Preliminary Economic Assessment (PEA) is scheduled for January 2025. The PEA will provide an early assessment of the project’s economic viability, based on estimated costs and revenues. The primary objectives are to explore the feasibility of a rapid restart of ore production, achieve positive cash flow with minimal investment, and produce an ore concentrate specifically suited for direct reduction processes. In addition, the assessment will examine possibilities for reducing the permitted volume of tailings deposited in the fjord outside Kirkenes. A full Feasibility Study for Sydvaranger is expected to follow in mid-2025.
Unexpected power issue cause for concern
During the quarter, GRANGEX has encountered challenges regarding the power supply for Dannemora, as Vattenfall and Svenska Kraftnät, despite ”intensive efforts” from GRANGEX, have not been able to confirm their ability to deliver the necessary power to the mine. This is a source of concern. Until GRANGEX gains clarity on this issue, it will be unable to proceed with project financing, which is why the procurement process for Dannemora has slowed down. Given that public institutions in Sweden are not known for moving quickly, except when it comes to imposing regulatory restrictions, we see a risk that this process may be prolonged, potentially positioning Sydvaranger as GRANGEX’s first producing mine. For now, we have chosen to delay the timetable for Dannemora by six months.
Short term headwind but long term support for iron ore
During the quarter, the 65% iron ore concentrate price index initially showed weak performance, with small premiums for high-grade concentrate due to low global steel demand and production surpluses. Fully integrated blast furnace steel mills have lowered demand for high-grade ore by using lower-grade iron ore. However, China’s recent stimulus measures to boost housing and investment have positively impacted the iron ore price index, with sharp increases in the 65% and 67.5% concentrate indices. The European steel industry’s transition and China’s carbon reduction targets are expected to drive demand for high-grade ore, supporting a positive long-term price trend for Sydvaranger’s and Dannemora’s products.
Pushing the major financing further down the line
The GRANGEX share has had surprising difficulty moving closer to fair value, primarily due to uncertainties surrounding the company’s future financing needs and the sheer scale of these requirements. The new uncertainty regarding power supply for Dannemora, which is in turn delaying the company’s ability to secure major financing for the project, now seems to be forcing further postponements—effectively requiring investors to muster even more patience as they await a rebuild of confidence in the stock.
Key milestones for investors
As the Sydvaranger deal has been closed and the updated DFS for Dannemora published, we now look forward to:
• Resolution of the power issue at Dannemora
• Final investment decision and commencement of drainage of Dannemora
• PEA study on the new conditions for Sydvaranger with a higher-quality product than before in Q1’25
• Updated DFS for Sydvaranger by mid 2025
• the major capital raise in 2025
• Production start in Dannemora now in 2027
• Final Investment Decision for Sydvaranger
DISCLAIMER
This commissioned research report is for informational purposes only and is to be considered marketing communication. This research does not constitute investment advice and is not a solicitation to buy shares. Information provided here or on Emergers’ website emergers.se is not intended to be financial advice. This research shall not be construed as a recommendation or solicitation to invest in the companies described. Emergers cannot be held liable for either direct or indirect damages caused by decisions made on the basis of information in this analysis. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.
This material is not intended to be financial advice. This material has been commissioned by the Company in question and prepared and issued by Emergers, in consideration of a fee payable by the Company. Emergers charges a standard fee for the production and broad dissemination of a detailed note following by regular update notes. Fees are paid upfront in cash without recourse. Emergers may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.
Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained herein represent those of the research analyst at Emergers at the time of publication. The company has been given the opportunity to influence factual statements before publication, but forecasts, conclusions and valuation reasoning are Emergers’ own. Forward-looking information or statements contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.
Exclusion of Liability: To the fullest extent allowed by law, Emergers shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained in this material.
No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Emergers’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in this material may not be eligible for sale in all jurisdictions or to certain categories of investors. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.
Investment in securities mentioned: Emergers has a restrictive policy relating to personal dealing and conflicts of interest. Emergers does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Emergers may have a position in any or related securities mentioned in this report, subject to Emergers’ policies on personal dealing and conflicts of interest.
Copyright: Copyright 2023 Incirrata AB (Emergers)
United Kingdom
This document is prepared and provided by Emergers for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.
This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ”FPO”) (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.
This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.
United States
Emergers relies upon the ”publishers’ exclusion” from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Emergers does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.
